BioInformant Worldwide, LLC | Stem Cell Industry Data

Can a patient's perspective impact commercialization?

Vein-to-Vein Congress full agenda released Dear Colleague, Investment into building safer, scalable and more cost-effective cell therapies for broader patient populations is growing, but do we understand wh ...